Compare LCUT & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LCUT | HOWL |
|---|---|---|
| Founded | 1945 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 64.5M |
| IPO Year | 1991 | 2021 |
| Metric | LCUT | HOWL |
|---|---|---|
| Price | $4.05 | $0.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $5.00 | ★ $7.00 |
| AVG Volume (30 Days) | 36.5K | ★ 533.0K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | ★ 4.21% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $659,066,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.43 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.89 | $0.60 |
| 52 Week High | $7.05 | $2.38 |
| Indicator | LCUT | HOWL |
|---|---|---|
| Relative Strength Index (RSI) | 67.32 | 37.76 |
| Support Level | $3.49 | $0.80 |
| Resistance Level | $3.97 | $1.02 |
| Average True Range (ATR) | 0.20 | 0.10 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 92.78 | 40.66 |
Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.